Grantham, Mayo, Van Otterloo & Co (GMO)’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
Other funds holding MPT
CIM
Grantham, Mayo, Van Otterloo & Co (GMO)'s MPT Position: Q4 2021 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Medical Properties Trust (MPT) in Q4 2021, closing a stake of 93,300 shares — an estimated $1.87M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MPT in Q4 2017 and held it in 4 quarters. The position peaked at $6.78M in Q2 2021. 634 funds tracked by Wall St. Rank hold MPT as of Q4 2021.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Medical Properties Trust position as of Q4 2021 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 93,300 Medical Properties Trust shares in Q4 2021, an estimated $1.87M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Medical Properties Trust in Q4 2017 and held it in 4 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Medical Properties Trust position peaked at $6.78M in Q2 2021.
- 634 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2021.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2021, filed 11 Feb 2022.